Twist Bioscience Corporation (TWST) – Strong Margin Performance

Twist Bioscience Corporation (TWST) (Q3FY23)

Stock Performance – Twist Bioscience’s stock price showed a volatile trend in
past 3 months. It gave 11.06% returns during the period. The stock price declined by 41.5% in past 1-year. The stock has a 52- week high of $40.50 and its 52-week low is $11.46. In the past 3 years, the stock has declined by 70.5%. TWST has a 50- day moving Avg. and 200-day moving Avg. of $22.36 and $20.14, respectively.

Revenue Performance – TWST revenues for the third quarter of fiscal 2023 were $63.7mn compared to $56.1mn for the same period of fiscal 2022. In the nine months ended June 30, 2023, cost of revenues increased to $113mn from $87.7mn in the nine months ended June 30, 2022.

Company Guidance for FY23 – TWST expect the revenue to be ~$241mn to $242mn for FY23. Gross margin is expected to be 36%, at the high end of the range of previous guidance of 35-36%. Operating expenses including R&D and SG&A are expected to be approximately $308mn.

Highlights

The company entered a new and significant market through the launch of a portfolio of RNA sequencing tools is a strategic move that can have a profound impact on a company’s growth and position in the industry. The company is diversifying its product offerings and entering a previously untapped market related to RNA sequencing tools.

This report is useful for M&A, business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.

Highlights

Valuation

– Enterprise Value
– CrispIdea Forecast
– Peer Valuation
– Economic Value Analysis
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Segment Performance
– Key Developments

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

CrispIdea Coverage

No of Pages: 31

To download the previous quarter’s equity/ report CLICK HERE

To Download other equity/ stock reports CLICK HERE

Follow our LinkedIn page for more updates.